|
|
Health authorities in the U.K. approved on Thursday Europe’s first clinical trial involving embryonic stem cells.
After a year of legal uncertainty, a federal judge ruled that U.S. taxpayer dollars can be used to support research on embryonic stem cells.
It’s been a good week for advocates of stem cell research, both politically and scientifically.
FDA Takes On Green Tea: Dr Pepper Snapple Group’s Canada Dry and Unilever’s Lipton are in hot water for overextended health claims on labels and promotional websites for their green tea products, reports the Los Angeles Times.
Although arthritis is extremely common, people still have many misconceptions about the disease. How much do you really know?
